AFP and liver disorder: According to the 2018 Practice Guidance by the American Association for the Study of Liver Diseases (5), the modality recommended for HCC surveillance in cirrhotic patients is ultrasound, with or without alpha-fetoprotein (AFP), every 6 months, indicating that AFP is not as important as ultrasound for HCC surveillance.